CLEARSIDE BIOMEDICAL INC (CLSD) Stock Income Statement
NASDAQ:CLSD - Nasdaq - US1850631045 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.76M | 1.66M | 8.23M | 1.33M | 29.58M | |||
| Cost Of Goods | 397.00K | 149.00K | 355.00K | 200.00K | N/A | |||
| Gross Profit | 3.37M | 1.51M | 7.87M | 1.12M | N/A | |||
| Operating Expenses | 29.25M | 30.40M | 32.72M | 31.41M | 30.20M | |||
| Research and Development | 17.44M | 18.59M | 20.85M | 19.63M | 18.54M | |||
| Selling, General, and Administrative Expenses | 11.81M | 11.81M | 11.87M | 11.77M | 11.67M | |||
| Operating Income | -25.88M | -28.88M | -24.84M | -30.28M | -620.00K | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | -5.50M | -6.93M | -9.36M | -3.34M | 0.00 | |||
| Non Recurring Items | 1.28M | 1.46M | 1.72M | 670.00K | 1.00M | |||
| Income Before Taxes | -30.10M | -34.35M | -32.48M | -32.95M | 380.00K | |||
| Income Tax | N/A | N/A | N/A | 0.00 | N/A | |||
| Net Income | -30.81M | -34.35M | -32.48M | -32.95M | 380.00K | |||
| EBITDA | -25.59M | -28.66M | -24.78M | -30.13M | -440.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.41 | -0.47 | -0.53 | -0.55 | 0.01 | |||
| Non GAAP EPS | -0.41 | -0.45 | -0.53 | -0.55 | -0.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.45% | 91.05% | 95.68% | 84.21% | N/A | |||
| Profit Margin | -818.57% | -2064.42% | -394.91% | -2477.44% | 1.28% | |||
| Operating Profit Margin | -687.51% | -1735.70% | -302.02% | -2276.69% | -2.10% | |||
All data in USD